logo-loader

Novacyt CEO David Allmond presents his first 100 days in the role and the latest trading update 2021

Published: 10:45 25 Jan 2022 GMT

Novacyt (LON: NCYT), an international specialist in clinical diagnostics, new CEO David Allmond joins Proactive London to discuss their unaudited trading update for the year ended 31 December 2021.

David Allmond’s also talks about his first 100 days with the company - together with a strategy update.

Reported revenues and EBITDA for the period are both expected to be in line with expectations with the 2021 audited full year results expected in the week commencing 25 April 2022.

Accesso's landmark deal with SEVEN marks strategic growth in the Saudi Market

Accesso Technology Group PLC (AIM:ACSO, OTC:LOQPF) chief executive Steve Brown joins Proactive's Stephen Gunnion with details of a significant partnership with Saudi Entertainment Ventures (SEVEN). Brown noted the collaboration highlights accesso's strategy to grow its global footprint,...

27 minutes ago